Literature DB >> 24865935

Characterization of the canine mda-7 gene, transcripts and expression patterns.

Maninder Sandey1, R Curtis Bird2, Swadesh K Das3, Devanand Sarkar4, David T Curiel5, Paul B Fisher4, Bruce F Smith6.   

Abstract

Human melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) displays potent growth suppressing and cell killing activity against a wide variety of human and rodent cancer cells. In this study, we identified a canine ortholog of the human mda-7/IL-24 gene located within a cluster of IL-10 family members on chromosome 7. The full-length mRNA sequence of canine mda-7 was determined, which encodes a 186-amino acid protein that has 66% similarity to human MDA-7/IL-24. Canine MDA-7 is constitutively expressed in cultured normal canine epidermal keratinocytes (NCEKs), and its expression levels are increased after lipopolysaccharide stimulation. In cultured NCEKs, the canine mda-7 pre-mRNA is differentially spliced, via exon skipping and alternate 5'-splice donor sites, to yield five splice variants (canine mda-7sv1, canine mda-7sv2, canine mda-7sv3, canine mda-7sv4 and canine mda-7sv5) that encode four protein isoforms of the canine MDA-7 protein. These protein isoforms have a conserved N-terminus (signal peptide sequence) and are dissimilar in amino acid sequences at their C-terminus. Canine MDA-7 is not expressed in primary canine tumor samples, and most tumor derived cancer cell lines tested, like its human counterpart. Unlike human MDA-7/IL-24, canine mda-7 mRNA is not expressed in unstimulated or lipopolysaccharide (LPS), concanavalin A (ConA) or phytohemagglutinin (PHA) stimulated canine peripheral blood mononuclear cells (PBMCs). Furthermore, in-silico analysis revealed that canonical canine MDA-7 has a potential 28 amino acid signal peptide sequence that can target it for active secretion. This data suggests that canine mda-7 is indeed an ortholog of human mda-7/IL-24, its protein product has high amino acid similarity to human MDA-7/IL-24 protein and it may possess similar biological properties to human MDA-7/IL-24, but its expression pattern is more restricted than its human ortholog.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Interleukin-24 (IL-24); Melanoma differentiation associated gene-7 (mda-7); cancer cell lines; canine

Mesh:

Substances:

Year:  2014        PMID: 24865935      PMCID: PMC4131717          DOI: 10.1016/j.gene.2014.05.054

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  74 in total

1.  Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effects.

Authors:  Hiroyasu Nagakawa; Osamu Shimozato; Ling Yu; Akihiko Wada; Kiyoko Kawamura; Quanhai Li; Sunil Chada; Yuji Tada; Yuichi Takiguchi; Koichiro Tatsumi; Masatoshi Tagawa
Journal:  Cell Immunol       Date:  2012-03-14       Impact factor: 4.868

Review 2.  The development of MDA-7/IL-24 as a cancer therapeutic.

Authors:  Paul Dent; Adly Yacoub; Hossein A Hamed; Margaret A Park; Rupesh Dash; Sujit K Bhutia; Devanand Sarkar; Xiang-Yang Wang; Pankaj Gupta; Luni Emdad; Irina V Lebedeva; Moira Sauane; Zhao-zhong Su; Mohamed Rahmani; William C Broaddus; Harold F Young; Maciej S Lesniak; Steven Grant; David T Curiel; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2010-08-21       Impact factor: 12.310

Review 3.  MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.

Authors:  Paul Dent; Adly Yacoub; Hossein A Hamed; Margaret A Park; Rupesh Dash; Sujit K Bhutia; Devanand Sarkar; Pankaj Gupta; Luni Emdad; Irina V Lebedeva; Moira Sauane; Zhao-Zhong Su; Mohamed Rahmani; William C Broaddus; Harold F Young; Maciej Lesniak; Steven Grant; David T Curiel; Paul B Fisher
Journal:  Anticancer Drugs       Date:  2010-09       Impact factor: 2.248

4.  A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.

Authors:  Margaret A Park; Hossein A Hamed; Clint Mitchell; Nichola Cruickshanks; Rupesh Dash; Jeremy Allegood; Igor P Dmitriev; Gary Tye; Besim Ogretmen; Sarah Spiegel; Adly Yacoub; Steven Grant; David T Curiel; Paul B Fisher; Paul Dent
Journal:  Mol Pharmacol       Date:  2010-11-30       Impact factor: 4.436

5.  Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells.

Authors:  Bao-Fu Zhang; Jun-Jie Liu; Dong-Sheng Pei; Zhi-Xia Yang; Jie-Hui Di; Fei-Fei Chen; Hui-Zhong Li; Wei Xu; Yong-Ping Wu; Jun-Nian Zheng
Journal:  Cancer Biother Radiopharm       Date:  2011-09-08       Impact factor: 3.099

6.  Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors.

Authors:  Cong-Jun Wang; Hui Zhang; Kun Chen; Jian-Wei Zheng; Chao-Wen Xiao; Wen-Wei Ji; Yuan Yu; Hui-Yi Hu; Yan Li; Xin-Bo Xue
Journal:  Oncol Res       Date:  2010       Impact factor: 5.574

7.  Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.

Authors:  Patrick J Eulitt; Margaret A Park; Hamed Hossein; Nichola Cruikshanks; Chen Yang; Igor P Dmitriev; Adly Yacoub; David T Curiel; Paul B Fisher; Paul Dent
Journal:  Cancer Biol Ther       Date:  2010-12-15       Impact factor: 4.742

8.  MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.

Authors:  Margaret A Park; Teneille Walker; Aditi Pandya Martin; Jeremy Allegood; Nicollaq Vozhilla; Luni Emdad; Devanand Sarkar; Mohammed Rahmani; Martin Graf; Adly Yacoub; Costas Koumenis; Sarah Spiegel; David T Curiel; Christina Voelkel-Johnson; Steven Grant; Paul B Fisher; Paul Dent
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

Review 9.  mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.

Authors:  Rupesh Dash; Sujit K Bhutia; Belal Azab; Zhao-zhong Su; Bridget A Quinn; Timothy P Kegelmen; Swadesh K Das; Keetae Kim; Seok-Geun Lee; Margaret A Park; Adly Yacoub; Mohammed Rahmani; Luni Emdad; Igor P Dmitriev; Xiang-Yang Wang; Devanand Sarkar; Steven Grant; Paul Dent; David T Curiel; Paul B Fisher
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

10.  Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.

Authors:  Rupesh Dash; Belal Azab; Bridget A Quinn; Xuening Shen; Xiang-Yang Wang; Swadesh K Das; Mohamed Rahmani; Jun Wei; Michael Hedvat; Paul Dent; Igor P Dmitriev; David T Curiel; Steven Grant; Bainan Wu; John L Stebbins; Maurizio Pellecchia; John C Reed; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

View more
  1 in total

Review 1.  Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.

Authors:  Jinkal Modi; Abhishek Roy; Anjan K Pradhan; Amit Kumar; Sarmistha Talukdar; Praveen Bhoopathi; Santanu Maji; Padmanabhan Mannangatti; Daniel Sanchez De La Rosa; Jiong Li; Chunqing Guo; Mark A Subler; Jolene J Windle; Webster K Cavenee; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Luni Emdad; Paul B Fisher
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.